ALLENA PHARMACEUTICALS INC (ALNAQ)
Institutional ownership reported to the SEC as of Q3 2022, across 16 quarters.
1
Reporting holders
$4.0K
Reported value
0.0%
Held as options
-22
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | $4.0K | 237,610 | 0.00% | 2q | -81.0%-$17.1K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2022 | 1 | $4.0K | 237,610 | 0 | 0 | 1 | 0.0% |
| Q2 2022 | 23 | $1.7M | 8,944,279 | 5 | 7 | 2 | 0.0% |
| Q1 2022 | 28 | $1.9M | 8,048,759 | 4 | 5 | 10 | 0.0% |
| Q4 2021 | 29 | $10.1M | 17,018,965 | 3 | 7 | 7 | 0.0% |
| Q3 2021 | 36 | $18.0M | 19,921,886 | 10 | 14 | 3 | 0.0% |
| Q2 2021 | 29 | $28.1M | 21,622,246 | 4 | 7 | 6 | 0.0% |
| Q1 2021 | 29 | $28.3M | 20,362,301 | 8 | 10 | 4 | 0.0% |
| Q4 2020 | 27 | $23.6M | 18,474,674 | 6 | 6 | 6 | 0.0% |
| Q3 2020 | 22 | $15.9M | 10,732,741 | 3 | 7 | 5 | 0.0% |
| Q2 2020 | 29 | $21.2M | 13,392,310 | 7 | 7 | 8 | 0.0% |
| Q1 2020 | 29 | $14.0M | 14,513,340 | 7 | 4 | 8 | 0.0% |
| Q4 2019 | 26 | $39.7M | 14,557,580 | 5 | 7 | 6 | 0.0% |
| Q3 2019 | 35 | $59.8M | 15,172,034 | 5 | 11 | 11 | 0.0% |
| Q2 2019 | 44 | $62.7M | 15,399,523 | 9 | 8 | 14 | 0.0% |
| Q1 2019 | 49 | $116.4M | 16,586,721 | 5 | 11 | 18 | 0.0% |
| Q4 2018 | 49 | $91.2M | 16,733,464 | 2 | 0 | 2 | 0.0% |